Research suggests confusion over funding of bisphosphonates means some women are not receiving the drug that could prevent their disease spreading Thousands of women with postmenopausal breast cancer are missing out on 43p-a-day drugs that could prevent their disease spreading, research suggests.
A poll of cancer specialists for the charity Breast Cancer Now found confusion over who funds bisphosphonates – cheap drugs typically used to treat osteoporosis.
Why do so many postmenopausal women who are treated for estrogen-sensitive breast cancer quit using drugs that help prevent the disease from recurring? The first study to actually ask the women themselves -- as well as the largest, ...
Exemestane, a drug used in the prevention of breast cancer in postmenopausal women, has a negative effect on bone density and structure in these women, despite calcium and vitamin D supplements.
The AZURE trial, led by Professor Robert Coleman from the University of Sheffield, has revealed that the bisphosphonate drug zoledronic acid boosts disease-free survival in postmenopausal breast cancer patients but may have an adver...
Wake Forest Baptist Medical Center has been awarded $4.4 million to conduct a multiple-site clinical trial testing the effectiveness of a statin drug in preventing cardiovascular events in women treated for breast cancer.